Oritavancin for serious heart infections
Part of Heart & circulation, Infections clinical trials.
This trial tests a newer antibiotic called oritavancin to treat serious infections of the heart (such as endocarditis or infections around pacemakers). You would receive this medication while hospitalized and be monitored closely to see if it works and is safe for your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You are hospitalized with a heart infection caused by a bacteria that tests show can be treated with oritavancin
- You have been fever-free for at least 24 hours and your blood cultures have cleared
- You have been on antibiotics for 1–2 weeks already and are doing well enough to switch medications
- You do not have severe kidney or liver disease, and are not on dialysis
- You agree to take oritavancin and attend follow-up visits for monitoring
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the antibiotic oritavancin can fight stubborn infections in pacemakers or similar heart devices caused by bacteria resistant to standard treatments. It may help people who cannot take common antibiotics due to allergies.
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
This trial measures how your body handles certain intravenous antibiotics used for endocarditis, an infection of the heart valves. It may help doctors understand the best antibiotic dosing for people with valve infections.
This trial tests if the antibiotic dalbavancin can effectively treat a certain type of serious heart valve infection (endocarditis) caused by specific bacteria. You may be eligible if you have this infection in your left-sided heart valves and are at least 18 years old.
This trial compares taking antibiotics by mouth versus receiving antibiotics through a vein (outpatient IV) for an infection of the heart valve. It’s designed to see whether the oral option can work as well and safely, especially after initial treatment and surgery if needed.
This trial is testing whether a shorter course of antibiotics (instead of the usual longer course) is safe and effective for people who have had an infection on the wires of their pacemaker or defibrillator, after the device has been completely removed.
Hear when a new Infective Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.